Koide T, Uyemura K
Eur J Pharmacol. 1980 Mar 21;62(2-3):147-55. doi: 10.1016/0014-2999(80)90271-x.
The effects of new non-tricyclic antidepressants, FS32 and its desmethylated compound (FS97), on the uptake of (3H)-dopamine (DA) by rat purified whole brain synaptosomes and the striatal synaptosomes were studied. The uptake into synaptosomes was time- and temperature-dependent and was saturable with a Km value of 9.1 X 10(-8) M. The inhibiting activities of both compounds were comparable to those of amitriptyline, nortriptyline and iprindole, and were nearly twice the activity of imipramine and desipramine. The kinetic constants indicated that both FS32 and FS97 were competitive inhibitors of (3H)-DA uptake. Neither drug caused a significant release of (3H)-DA from the synaptosomes.
研究了新型非三环类抗抑郁药FS32及其去甲基化化合物(FS97)对大鼠纯化全脑突触体和纹状体突触体摄取(3H)-多巴胺(DA)的影响。突触体摄取呈时间和温度依赖性,且具有饱和性,Km值为9.1×10(-8)M。两种化合物的抑制活性与阿米替林、去甲替林和茚满二酮相当,几乎是丙咪嗪和地昔帕明活性的两倍。动力学常数表明,FS32和FS97都是(3H)-DA摄取的竞争性抑制剂。两种药物均未引起突触体中(3H)-DA的显著释放。